THE INFLUENCE OF THE GUT MICROBIOTA ON THE EFFICACY AND TOXICITY OF RADIOTHERAPY IN CANCER TREATMENT: A LITERATURE REVIEW
DOI:
https://doi.org/10.31435/ijitss.4(52).2026.6829Keywords:
Gut Microbiota, Radiotherapy, Radiation-Induced Toxicity, Radiosensitivity, Probiotics, Faecal Microbiota TransplantationAbstract
Radiotherapy is a cornerstone of cancer treatment, yet its effectiveness is limited by toxicity to healthy tissues, particularly the gastrointestinal mucosa. The gut microbiota interacts with radiotherapy in both directions, ionizing radiation alters its composition and function, and its state may influence tumour response and the severity of adverse effects. This narrative review, based on a search of the biomedical literature, aims to summarize current knowledge on the mechanisms by which radiotherapy affects tissues and the microbiota, the role of the microbiota in radiosensitivity and radioresistance, including the immune response, the tumour microenvironment, bacterial metabolites and its significance in the pathogenesis and prediction of radiation toxicity. Strategies for modifying the microbiota are also discussed: diet, prebiotics, probiotics, postbiotics, synbiotics, faecal microbiota transplantation, bacteriophages and genetically modified bacteria. The influence of the microbiota on radiotherapy toxicity is the best documented, and its composition before treatment may help to identify patients at risk of acute intestinal toxicity. Probiotics have been studied most extensively in clinical trials, but their efficacy remains inconsistent, particularly for severe complications. Evidence that the microbiota affects antitumour efficacy is mainly preclinical and correlative. Small samples, methodological heterogeneity, confounding factors and limited safety data in immunocompromised patients constrain interpretation. Well-designed prospective and interventional studies are needed.
References
Al-Qadami, G., Van Sebille, Y., Le, H., & Bowen, J. (2019). Gut microbiota: Implications for radiotherapy response and radiotherapy-induced mucositis. Expert Review of Gastroenterology & Hepatology, 13(5), 485–496. https://doi.org/10.1080/17474124.2019.1595586
Bortolus, R., Cannizzaro, R., Maiero S., Pelizzo P., Gulotta M., Facchin S., Tessarolo G., Zucchetto A., Matrone F., Realdon S. (2025). Microencapsulated sodium butyrate in patients undergoing radiotherapy for prostate cancer: A prospective single-arm study. Journal of Clinical Medicine, 14(13), Article 4783. https://doi.org/10.3390/jcm14134783
Bowen, J. M., Gibson, R. J., Coller, J. K., Blijlevens N., Bossi P., Al-Dasooqi N., Bateman EH, Chiang K., de Mooij C., Mayo B., Stringer AM., Tissing W., Wardill HR., van Sebille YZA., Ranna V., Vaddi A., Keefe DM., Lalla RV., Cheng KKF., Elad S. (2019). Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines. Supportive Care in Cancer, 27(10), 4011-4022 https://doi.org/10.1007/s00520-019-04892-0
Cai, S., Xie, L.-W., Xu, J.-Y., Zhou H., Yang C., Tang LF., Tian Y., Li M. (2022). (−)-Epigallocatechin-3-gallate (EGCG) modulates the composition of the gut microbiota to protect against radiation-induced intestinal injury in mice. Frontiers in Oncology, 12, Article 848107. https://doi.org/10.3389/fonc.2022.848107
Chen, Z., Wang, B., Dong, J., Li Y., Zhang S., Zeng X., Xiao H., Fan S., Cui M. (2021a). Gut microbiota-derived L-histidine/imidazole propionate axis fights against the radiation-induced cardiopulmonary injury. International Journal of Molecular Sciences, 22(21), Article 11436. https://doi.org/10.3390/ijms222111436
Chen, Z., Xiao, H., Dong, J., Li Y., Wang B., Fan SJ., Cui M. (2021b). Gut microbiota-derived PGF2α fights against radiation-induced lung toxicity through the MAPK/NF-κB pathway. Antioxidants, 11(1), Article 65. https://doi.org/10.3390/antiox11010065
Chitapanarux, I., Chitapanarux, T., Traisathit, P., Kudumpee S., Tharavichitkul E., Lorvidhaya V. (2010). Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiation Oncology, 5, Article 31. https://doi.org/10.1186/1748-717X-5-31
Ciorba, M. A., Riehl, T. E., Rao, M. S., Moon C., Ee X., Nava G.M., Walker M.R., Marinshaw J.M., Stappenbeck T.S., Stenson W.F. (2012). Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclooxygenase-2-dependent manner. Gut, 61(6), 829–838. https://doi.org/10.1136/gutjnl-2011-300367
Crawford, P. A., & Gordon, J. I. (2005). Microbial regulation of intestinal radiosensitivity. Proceedings of the National Academy of Sciences of the United States of America, 102(37), 13254–13259. https://doi.org/10.1073/pnas.0504830102
Cui, M., Xiao, H., Luo, D., Zhang X., Zhao S., Zheng Q., Li Y., Zhao Y., Dong J., Li H., Wang H., Fan S. (2016). Circadian rhythm shapes the gut microbiota affecting host radiosensitivity. International Journal of Molecular Sciences, 17(11), Article 1786. https://doi.org/10.3390/ijms17111786
Cui, M., Xiao, H., Li, Y., Zhou L., Zhao S., Luo D., Zheng Q., Dong J., Zhao Y., Zhang X., Zhang J., Lu L., Wang H., Fan S. (2017). Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Molecular Medicine, 9(4), 448–461. https://doi.org/10.15252/emmm.201606932
Danis, R., Mego M., Antonova M., Stepanova R., Svobodnik A., Hejnova R., Wawruch M. (2022). Probiotics in the prevention of radiation-induced diarrhea: A systematic review and meta-analysis of randomized controlled trials. Integrative Cancer Therapies, 21, Article 15347354221144309. https://doi.org/10.1177/15347354221144309
Delia, P., Sansotta, G., Donato, V., Frosina P., Messina G., De Renzis C., Famularo G. (2007). Use of probiotics for prevention of radiation-induced diarrhea. World Journal of Gastroenterology, 13(6), 912–915. https://doi.org/10.3748/wjg.v13.i6.912
Demers, M., Dagnault, A., & Desjardins, J. (2014). A randomized double-blind controlled trial: Impact of probiotics on diarrhea in patients treated with pelvic radiation. Clinical Nutrition, 33(5), 761–767. https://doi.org/10.1016/j.clnu.2013.10.015
Devaraj, N. K., Suppiah, S., Veettil, S. K., Ching S.M., Lee K.W., Menon R.K., Soo M.J., Deuraseh I., Hoo F.K., Sivaratnam D. (2019). The effects of probiotic supplementation on the incidence of diarrhea in cancer patients receiving radiation therapy: A systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. Nutrients, 11(12), Article 2886. https://doi.org/10.3390/nu11122886
Ding, X., Li, Q., Li, P., Chen X., Xiang L., Bi L., Zhu J., Huang X., Cui B., Zhang F. (2020). Fecal microbiota transplantation: A promising treatment for radiation enteritis? Radiotherapy and Oncology, 143, 12–18. https://doi.org/10.1016/j.radonc.2020.01.011
Dong, J., Li, Y., Xiao, H., Zhang, S., Wang, B., Wang, H., Li, Y., Fan, S., & Cui, M. (2021). Oral microbiota affects the efficacy and prognosis of radiotherapy for colorectal cancer in mouse models. Cell Reports, 37(4), Article 109886. https://doi.org/10.1016/j.celrep.2021.109886
Fan, Q., Shang, F., Chen, C., Zhou, H., Fan, J., Yang, M., Nie, X., Liu, L., Cai, K., & Liu, H. (2021). Microbial characteristics of locally advanced rectal cancer patients after neoadjuvant chemoradiation therapy according to pathologic response. Cancer Management and Research, 13, 2655–2667. https://doi.org/10.2147/CMAR.S294936
García-Peris, P., Velasco, C., Hernández, M., Lozano M.A., Paron L., de la Cuerda C., Breton I., Camblor M., Guarner F. (2016). Effect of inulin and fructo-oligosaccharide on the prevention of acute radiation enteritis in patients with gynecological cancer and impact on quality-of-life: A randomized, double-blind, placebo-controlled trial. European Journal of Clinical Nutrition, 70(2), 170–174. https://doi.org/10.1038/ejcn.2015.192
Giralt, J., Regadera, J. P., Verges, R., Romero J., de la Fuente I., Biete A., Villoria J., Cobo J.M., Guarner F. (2008). Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: Results from multicenter, randomized, placebo-controlled nutritional trial. International Journal of Radiation Oncology*Biology*Physics, 71(4), 1213–1219. https://doi.org/10.1016/j.ijrobp.2007.11.009
Guo, H., Chou, W.-C., Lai, Y., Liang K., Tam J.W., Brickey W.J., Chen L., Montgomery N.D., Li X., Bohannon L.M., Sung A.D., Chao N.J., Peled J.U., Gomes A.L.C., van den Brink M.R.M., French M.J., Macintyre A.N., Sempowski G.D., Tan X., Sartor R.B., Lu K., Ting J.P.Y. (2020). Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites. Science, 370(6516), Article eaay9097. https://doi.org/10.1126/science.aay9097
Huang, R., Xiang, J., & Zhou, P. (2019). Vitamin D, gut microbiota, and radiation-related resistance: A love–hate triangle. Journal of Experimental & Clinical Cancer Research, 38(1), Article 493. https://doi.org/10.1186/s13046-019-1499-y
Huang, X., Chen, C., Xie, W., Zhou C., Tian X., Zhang Z., Wang Q., Chang H., Xiao W., Zhang R., Gao Y. (2023). Metagenomic analysis of intratumoral microbiome linking to response to neoadjuvant chemoradiotherapy in rectal cancer. International Journal of Radiation Oncology*Biology*Physics, 117(5), 1255–1269. https://doi.org/10.1016/j.ijrobp.2023.06.2515
Iacovacci, J., Serafini M.S., Avuzzi B., Badenchini F., Cicchetti A., Devecchi A., Dispinzieri M., Doldi V., Giandini T., Gioscio E., Mancinelli E., Noris Chiorda B., Orlandi E., Palorini F., Possenti L., Reis Ferreira M., Villa S., Zaffaroni N., De Cecco L., Valdagni R., Rancati T. (2024). Intestinal microbiota composition before radiotherapy predicts acute gastrointestinal toxicity in prostate cancer patients (MicroLearner). eBioMedicine, 106, Article 105246. https://doi.org/10.1016/j.ebiom.2024.105246
Jian, Y.P, Yang, G., Zhang, L.H., Liang J.Y., Zhou H.L., Wang Y.S., Xu Z.X. (2022). Lactobacillus plantarum alleviates irradiation-induced intestinal injury by activation of FXR-FGF15 signaling in intestinal epithelia. Journal of Cellular Physiology, 237(3), 1845–1856. https://doi.org/10.1002/jcp.30651
Jo, Y. Y., Kim Y.J., Lee S.H., Kim Y.S. (2024). Probiotics for the prevention of radiation-induced enteropathy in patients receiving pelvic radiotherapy: A randomized, double-blind, placebo-controlled trial (PREP). Current Oncology, 31(10), 5872–5883. https://doi.org/10.3390/curroncol31100438
Kordahi, M. C., & Chassaing, B. (2021). The intestinal microbiota: Our best frenemy in radiation-induced damages? Cell Host & Microbe, 29(1), 7–9. https://doi.org/10.1016/j.chom.2020.12.013
Li, L., Yang, Z., Yi, Y., Song, Y., & Zhang, W. (2025). Gut microbiota and radiation-induced injury: Mechanistic insights and microbial therapies. Gut Microbes, 17(1), Article 2528429. https://doi.org/10.1080/19490976.2025.2528429
Li, W., Lu, L., Liu, B., & Qin, S. (2020). Effects of phycocyanin on pulmonary and gut microbiota in a radiation-induced pulmonary fibrosis model. Biomedicine & Pharmacotherapy, 132, Article 110826. https://doi.org/10.1016/j.biopha.2020.110826
Li, Z., Ke, X., Zuo, D., Wang, Z., Fang, F., & Li, B. (2023). New insights into the relationship between gut microbiota and radiotherapy for cancer. Nutrients, 15(1), Article 48. https://doi.org/10.3390/nu15010048
Lin, D., El Alam M.B., Jaoude J.A., Kouzy R., Phan J.L., Elnaggar J.H., Resendiz B., Medrano A.Y.D., Lynn E.J., Nguyen N.D., Noticewala S.S., Mathew G.G., Holliday E.B., Minsky B.D., Das P., Morris V.K., Eng C., Mezzari M.P., Petrosino J.F., Ajami N.J., Klopp A.H., Taniguchi C.M., Colbert L.E. (2022). Microbiome dynamics during chemoradiation therapy for anal cancer. International Journal of Radiation Oncology*Biology*Physics, 113(5), 974–984. https://doi.org/10.1016/j.ijrobp.2022.04.037
Linn, Y. H., Thu, K. K., & Win, N. H. H. (2019). Effect of probiotics for the prevention of acute radiation-induced diarrhoea among cervical cancer patients: A randomized double-blind placebo-controlled study. Probiotics and Antimicrobial Proteins, 11(2), 638–647. https://doi.org/10.1007/s12602-018-9408-9
Liu, L., Chen, Y., Liu X., Chen B., Ding C., Liang J. (2021). Gut microbiota in patients with chronic radiation proctitis after pelvic radiotherapy for gynecologic malignancies. Frontiers in Oncology, 11, Article 637265. https://doi.org/10.3389/fonc.2021.637265
Liu, M.-M., Li, S.-T., Shu, Y., Zhan H.Q. (2017). Probiotics for prevention of radiation-induced diarrhea: A meta-analysis of randomized controlled trials. PLoS ONE, 12(6), Article e0178870. https://doi.org/10.1371/journal.pone.0178870
Lu, W., Shen, L., Wang Y., Zhang J., Li Y., Huang L., Yang W., Zhou S., Zhou M., Chen Y., Wu R., Wang Y., Zhang H., Wan J., Xia F., Zhang Z. (2026). Longitudinal multi-omic profiling of the gut microbiome during immunotherapy-based total neoadjuvant therapy in locally advanced rectal cancer. Frontiers in Immunology, 17, Article 1871586. https://doi.org/10.3389/fimmu.2026.1871586
Luo, X.-X., Yang, C., Zhan, G.F., Li S., Hua D.Y., Luo A.L., Yuan X.L. (2020). Whole brain radiotherapy induces cognitive dysfunction in mice: Key role of gut microbiota. Psychopharmacology, 237(7), 2089–2101. https://doi.org/10.1007/s00213-020-05520-0
Ma, C.Y., Zhou, J.-Y. (2024). Characteristics of the gut microbiota and enterotypes in patients with severe acute radiation enteritis during pelvic radiotherapy for cervical cancer. BMC Microbiology, 24, Article 456. https://doi.org/10.1186/s12866-024-03620-x
Maggio, A., Magli, A., Rancati, T., Fiorino C., Valvo F., Fellin G., Ricardi U., Munoz F., Cosentino D., Cazzaniga L.F., Valdagni R., Vavassori V. (2014). Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: Results of a multicenter randomized placebo-controlled dose-finding phase 2 study. International Journal of Radiation Oncology*Biology*Physics, 89(3), 518–524. https://doi.org/10.1016/j.ijrobp.2014.03.018
Manichanh, C., Varela, E., Martinez, C., Antolin M., Llopis M., Doré J., Giralt J., Guarner F., Malagelada J.R. (2008). The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. The American Journal of Gastroenterology, 103(7), 1754–1761. https://doi.org/10.1111/j.1572-0241.2008.01868.x
Mitra, A., Grossman Biegert, G. W., Delgado, A. Y., Karpinets T.V., Solley T.N., Mezzari M.P., Yoshida-Court K., Petrosino J.F., Mikkelson M.D., Lin L., Eifel P., Zhang J., Ramondetta L.M., Jhingran A., Sims T.T., Schmeler K., Okhuysen P., Colbert L.E., Klopp A.H. (2020). Microbial diversity and composition is associated with patient-reported toxicity during chemoradiation therapy for cervical cancer. International Journal of Radiation Oncology*Biology*Physics, 107(1), 163–171. https://doi.org/10.1016/j.ijrobp.2019.12.040
Muangwong, P., Tharavichitkul E., Thiennimitr P., Chitapanarux I., Kittidachanan K., Chitapanarux T.. (2025). Impact of Saccharomyces boulardii on acute gastrointestinal toxicities in patients undergoing pelvic radiotherapy for gynecologic cancers: a randomized controlled trial. Supportive Care in Cancer, 33, Article 566. https://doi.org/10.1007/s00520-025-09663-8
Nam, Y.D., Kim, H. J., Seo, J.G., Kang S.W., Bae J.W. (2013). Impact of pelvic radiotherapy on gut microbiota of gynecological cancer patients revealed by massive pyrosequencing. PLoS ONE, 8(12), Article e82659. https://doi.org/10.1371/journal.pone.0082659
Paulos, C. M., Wrzesinski, C., Kaiser, A., Hinrichs C.S., Chieppa M., Cassard L., Palmer D.C., Boni A., Muranski P., Yu Z., Gattinoni L., Antony P.A., Rosenberg S.A., Restifo N.P. (2007). Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. Journal of Clinical Investigation, 117(8), 2197–2204. https://doi.org/10.1172/JCI32205
Pinto, A., Fidalgo, P., Cravo, M., Midões J., Chaves P., Rosa J., dos Anjos Brito M., Leitão C.N. (1999). Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: Randomized, double-blind, controlled trial. Diseases of the Colon & Rectum, 42(6), 788–795. https://doi.org/10.1007/BF02236937
Redman, M. G., Ward, E. J., & Phillips, R. S. (2014). The efficacy and safety of probiotics in people with cancer: A systematic review. Annals of Oncology, 25(10), 1919–1929. https://doi.org/10.1093/annonc/mdu106
Reis Ferreira, M., Andreyev, H. J. N., Mohammed, K., Truelove L., Gowan S.M., Li J., Gulliford S.L., Marchesi J.R., Dearnaley D.P. (2019). Microbiota- and radiotherapy-induced gastrointestinal side-effects (MARS) study: A large pilot study of the microbiome in acute and late-radiation enteropathy. Clinical Cancer Research, 25(21), 6487–6500. https://doi.org/10.1158/1078-0432.CCR-19-0960
Riehl, T. E., Alvarado, D., Ee, X., Zuckerman A., Foster L., Kapoor V., Thotala D., Ciorba M.A., Stenson W.F. (2019). Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells. Gut, 68(6), 1003–1013. https://doi.org/10.1136/gutjnl-2018-316226
Rosli, D., Shahar, S., Manaf, Z. A., Lau H.J., Yusof N.Y.M., Haron M.R., Majid H.A. (2021). Randomized controlled trial on the effect of partially hydrolyzed guar gum supplementation on diarrhea frequency and gut microbiome count among pelvic radiation patients. Journal of Parenteral and Enteral Nutrition, 45(2), 277–286. https://doi.org/10.1002/jpen.1987
Sasaki, T., Matsumoto Y., Murakami K., Endo S., Toyozumi T., Otsuka R., Kinoshita K., Hu J., Iida S., Morishita H., Nishioka Y., Nakano A., Uesato M., Matsubara H. (2023). Gut microbiome can predict chemoradiotherapy efficacy in patients with esophageal squamous cell carcinoma. Esophagus, 20(4), 691–703. https://doi.org/10.1007/s10388-023-01004-0
Sasidharan, B. K., Ramadass, B., Viswanathan, P. N., Samuel, P., Gowri, M., Pugazhendhi, S., & Ramakrishna, B. S. (2019). A phase 2 randomized controlled trial of oral resistant starch supplements in the prevention of acute radiation proctitis in patients treated for cervical cancer. Journal of Cancer Research and Therapeutics, 15(6), 1383–1391. https://doi.org/10.4103/jcrt.JCRT_152_19
Shaikh, F. Y., Lee S., White J.R., Zhao Y., Ferri J.T., Pereira G., Landon B.V., Ke S., Hu C., Feliciano J.L., Hales R.K., Voong K.R., Battafarano R.J., Yang S.C., Broderick S., Ha J., Thompson E., Shin E.J., Bartlett D.L., Weksler B., Pardoll D.M., Anagnostou V., Lam V.K., Zaidi A.H., Kelly R.J., Sears C.L. (2024). Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy. Cancers, 16(21), Article 3644. https://doi.org/10.3390/cancers16213644
Sims, T. T., El Alam, M. B., Karpinets, T. V., Dorta-Estremera, S., Hegde, V. L., Nookala, S., Yoshida-Court, K., Wu, X., Biegert, G. W. G., Delgado Medrano, A. Y., Solley, T., Ahmed-Kaddar, M., Chapman, B. V., Sastry, K. J., Mezzari, M. P., Petrosino, J. F., Lin, L. L., Ramondetta, L., Jhingran, A., Klopp, A. H. (2021). Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Communications Biology, 4(1), Article 237. https://doi.org/10.1038/s42003-021-01741-x
Stene, C., Xu J., Fallone de Andrade S., Palmquist I., Molin G., Ahrné S., Thorlacius H., Johnson L.B., Jeppsson B. (2025). Synbiotics protected radiation-induced tissue damage in rectal cancer patients: A controlled trial. Clinical Nutrition, 48, 89–99. https://doi.org/10.1016/j.clnu.2025.03.025
Talley, N. A., Chen, F., King, D., Jones M., Talley N.J. (1997). Short-chain fatty acids in the treatment of radiation proctitis: A randomized, double-blind, placebo-controlled, cross-over pilot trial. Diseases of the Colon & Rectum, 40(9), 1046–1050. https://doi.org/10.1007/BF02050927
Teng, H., Wang, Y., Sui, X., Fan J., Li S., Lei X., Shi C., Sun W., Song M., Wang H., Dong D., Geng J., Zhang Y., Zhu X., Cai Y., Li Y., Li B., Min Q., Wang .W, Zhan Q. (2023). Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer. Cancer Cell, 41(1), 124–138.e6. https://doi.org/10.1016/j.ccell.2022.11.013
Tian, J., Rodgers, M., Epperly, M., Mollen K., Greenberger J.S., Morowitz M., (2019). The gut microbe Akkermansia muciniphila increases after radiation injury and can be supplemented by gavage to improve survival in radiated mice. International Journal of Radiation Oncology*Biology*Physics, 105(1), S1.
Uribe-Herranz, M., Rafail, S., Beghi, S., Gil-de-Gómez L., Verginadis I., Bittinger K., Pustylnikov S., Pierini S., Perales-Linares R., Blair I.A., Mesaros C.A., Snyder N.W., Bushman F., Koumenis C., Facciabene A. (2020). Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. Journal of Clinical Investigation, 130(1), 466–479. https://doi.org/10.1172/JCI124332
Vernia, P., Fracasso, P. L., Casale, V., Villotti G., Marcheggiano A., Stigliano V., Pinnaro P., Bagnardi V., Caprilli R. (2000). Topical butyrate for acute radiation proctitis: Randomised, crossover trial. The Lancet, 356(9237), 1232–1235. https://doi.org/10.1016/S0140-6736(00)02787-2
Wang, A., Ling, Z., Yang, Z., Kiela P.R., Wang T., Wang C., Cao L., Geng F., Shen M., Ran X., Su Y., Cheng T., Wang J. (2015). Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: A pilot study. PLoS ONE, 10(5), Article e0126312. https://doi.org/10.1371/journal.pone.0126312
Wang, L., Li Y., Zhang Y.J., Peng L.H. (2024). Intestinal microecological transplantation for a patient with chronic radiation enteritis: A case report. World Journal of Gastroenterology, 30(19), 2603–2610. https://doi.org/10.3748/wjg.v30.i19.2603
Wang, Z., Wang, Q., Wang, X., Zhu L., Chen J., Zhang B., Chen Y., Yuan Z. (2019). Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy. Journal of Cellular and Molecular Medicine, 23(5), 3747–3756. https://doi.org/10.1111/jcmm.14289
Wang, Z., Dan, W., Zhang, N., Fang, J., & Yang, Y. (2023). Colorectal cancer and gut microbiota studies in China. Gut Microbes, 15(1), Article 2236364. https://doi.org/10.1080/19490976.2023.2236364
Wei, D., Heus, P., van de Wetering, F. T., van Tienhoven G., Verleye L., Scholten R.J. (2018). Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer. Cochrane Database of Systematic Reviews, 2018(8), Article CD008831. https://doi.org/10.1002/14651858.CD008831.pub3
Xia, C., Jiang, C., Li, W., Wei J., Hong H., Li J., Feng L., Wei H., Xin H., Chen T. (2021). A phase II randomized clinical trial and mechanistic studies using improved probiotics to prevent oral mucositis induced by concurrent radiotherapy and chemotherapy in nasopharyngeal carcinoma. Frontiers in Immunology, 12, Article 618150. https://doi.org/10.3389/fimmu.2021.618150
Xiao, C., Fedirko, V., Beitler, J., Bai J., Peng G., Zhou C., Gu J., Zhao H., Lin I.H., Chico C.E., Jeon S., Knobf T.M., Conneely K.N., Higgins K., Shin D.M., Saba N., Miller A., Bruner D. (2021). The role of the gut microbiome in cancer-related fatigue: Pilot study on epigenetic mechanisms. Supportive Care in Cancer, 29(6), 3173–3182. https://doi.org/10.1007/s00520-020-05820-3
Xie, L., Cai, S., Lu, H.Y., Tang F.L., Zhu R.Q., Tian Y., Li M. (2024). Microbiota-derived I3A protects the intestine against radiation injury by activating AhR/IL-10/Wnt signaling and enhancing the abundance of probiotics. Gut Microbes, 16(1), Article 2347722. https://doi.org/10.1080/19490976.2024.2347722
Yi, Y., Shen, L., Shi, W., Xia F., Zhang H., Wang Y., Zhang J., Wang Y., Sun X., Zhang Z., Zou W., Yang W., Zhang L., Zhu J., Goel A., Ma Y., Zhang Z. (2021). Gut microbiome components predict response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: A prospective, longitudinal study. Clinical Cancer Research, 27(5), 1329–1340. https://doi.org/10.1158/1078-0432.CCR-20-3445
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Karina Udrycka, Kacper Wrzosek, Agata Zielińska , Kamil Rutkowski, Magdalena Ślifierska

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

